Faecal microbiota signatures of IBD and their relation to diagnosis, disease phenotype, inflammation, treatment escalation and anti-TNF response in a European Multicentre Study (IBD-Character)

S. Vatna Department of Gastroenterology, Division of Medicine, Akershus University Hospital, Lørenskog, Norway;b Institute of Clinical Medicine, University of Oslo, Oslo, NorwayCorrespondence[email protected]

https://orcid.org/0000-0002-6124-4995 View further author information

A. Carstensc Department of Gastroenterology, Faculty of Medicine and Health, Örebro University, Örebro, Sweden;d Department of Internal Medicine, Ersta Hospital, Stockholm, SwedenView further author information

A. B. Kristoffersene Genetic Analysis AS, Oslo, NorwayView further author information

D. Bergemalmc Department of Gastroenterology, Faculty of Medicine and Health, Örebro University, Örebro, SwedenView further author information

C. Caséne Genetic Analysis AS, Oslo, Norway

https://orcid.org/0000-0002-7632-8251 View further author information

A. E. F. Moenb Institute of Clinical Medicine, University of Oslo, Oslo, Norway;f Department of Clinical Molecular Biology (EpiGen), Division of Medicine, Akershus University Hospital, Lørenskog, NorwayView further author information

T. M. Tannaesb Institute of Clinical Medicine, University of Oslo, Oslo, Norway;f Department of Clinical Molecular Biology (EpiGen), Division of Medicine, Akershus University Hospital, Lørenskog, NorwayView further author information

J. Lindstrømb Institute of Clinical Medicine, University of Oslo, Oslo, Norway;g Health Services Research Unit, Akershus University Hospital, Lørenskog, Norway;h Department of Pediatric and Adolescent Medicine, Akershus University Hospital, Lørenskog, NorwayView further author information

T. E. Detliea Department of Gastroenterology, Division of Medicine, Akershus University Hospital, Lørenskog, Norway;b Institute of Clinical Medicine, University of Oslo, Oslo, Norway

https://orcid.org/0000-0002-1576-5298 View further author information

C. Olbjørnb Institute of Clinical Medicine, University of Oslo, Oslo, Norway;i Department of Clinical and Experimental Medicine, Faculty of Health Sciences, Linköping University, Linköping, SwedenView further author information

C. M. Lindquistc Department of Gastroenterology, Faculty of Medicine and Health, Örebro University, Örebro, SwedenView further author information

J. D. Söderholmj Digestive Diseases Unit, IIS Aragón, Zaragoza, SpainView further author information

F. Gomollónk Gastrointestinal Unit, Centre for Genomics and Molecular Medicine, Division of Medical and Radiological Sciences, University of Edinburgh, Edinburgh, UKView further author information

R. Kallal Translational Gastroenterology Unit, Medical Sciences/Experimental Medicine Division, University of Oxford, Oxford, UKView further author information

J. Satsangil Translational Gastroenterology Unit, Medical Sciences/Experimental Medicine Division, University of Oxford, Oxford, UKView further author information

M. H. Vatnb Institute of Clinical Medicine, University of Oslo, Oslo, NorwayView further author information

J. Jahnsena Department of Gastroenterology, Division of Medicine, Akershus University Hospital, Lørenskog, Norway;b Institute of Clinical Medicine, University of Oslo, Oslo, Norway

https://orcid.org/0000-0002-0419-2914 View further author information

J. Halfvarsonc Department of Gastroenterology, Faculty of Medicine and Health, Örebro University, Örebro, SwedenView further author information

P. Ricaneka Department of Gastroenterology, Division of Medicine, Akershus University Hospital, Lørenskog, NorwayView further author information

& the IBD-Character Consortium show all

Faecal microbiota signatures of IBD and their relation to diagnosis, disease phenotype, inflammation, treatment escalation and anti-TNF response in a European Multicentre Study (IBD-Character)

Supplemental Material

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Faecal microbiota signatures of IBD and their relation to diagnosis, disease phenotype, inflammation, treatment escalation and anti-TNF response in a European Multicentre Study (IBD-Character)

Supplemental Material

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date